levodopa has been researched along with retinol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dubois-Poulsen, A | 1 |
| Laufer, J | 1 |
| Aguilar, MV; de Bustos, F; González-Muñoz, MJ; Jiménez-Jiménez, FJ; Martínez-Para, MC; Martínez-Salio, A; Mateos-Vega, CJ; Meseguer, I; Molina, JA; Ortí-Pareja, M; Zurdo, M | 1 |
| Albratty, M; Alhazmi, HA; Anwer, MK; Behl, T; Madaan, P; Makeen, HA; Meraya, AM; Sehgal, A; Verma, R | 1 |
6 other study(ies) available for levodopa and retinol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Ocular consequences of systemic therapy].
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Eye Diseases; Glaucoma; Humans; Levodopa; Myelitis; Optic Neuritis; Phenothiazines; Syndrome; Vitamin A | 1977 |
[Current treatment in diseases of the oral mucosa].
Topics: Adrenal Cortex Hormones; Candidiasis, Oral; Humans; Levamisole; Levodopa; Mouth Diseases; Mycoses; Tretinoin; Virus Diseases; Vitamin A | 1978 |
Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Blood Proteins; Copper; Dopamine Agonists; Female; Humans; Iron; Levodopa; Male; Manganese; Metals, Heavy; Middle Aged; Nutritional Status; Parkinson Disease; Reference Values; Selegiline; Spectrophotometry, Atomic; Trace Elements; Vitamin A; Zinc | 1998 |
Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives.
Topics: Antioxidants; Humans; Levodopa; Parkinson Disease; Vitamin A; Vitamin K; Vitamins | 2023 |